Radiogenomics in Renal Cancer Management—Current Evidence and Future ProspectsMatteo Ferro, Octavian Sabin Tătaru, Gennaro Musi et al.|International Journal of Molecular Sciences|2023Cited by 124
Radiomics in prostate cancer: an up-to-date reviewMatteo Ferro, Octavian Sabin Tătaru, Ottavio De Cobelli et al.|Therapeutic Advances in Urology|2022Cited by 117
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature reviewMatteo Ferro, Octavian Sabin Tătaru, Gian Maria Busetto et al.|Therapeutic Advances in Urology|2023Cited by 103
Neutrophil percentage-to-albumin Ratio Predicts Mortality in Bladder Cancer Patients Treated With Neoadjuvant Chemotherapy Followed By Radical CystectomyMatteo Ferro, Mihai Dorin Vartolomei, Dragoș-Florin Babă et al.|Future Science OA|2021Cited by 79
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancerMatteo Ferro, Mihai Dorin Vartolomei, Biagio Barone et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 56